95 related articles for article (PubMed ID: 21653658)
1. mTOR-RAPTOR and 14-3-3σ immunohistochemical expression in high grade prostatic intraepithelial neoplasia and prostatic adenocarcinomas: a tissue microarray study.
Evren S; Dermen A; Lockwood G; Fleshner N; Sweet J
J Clin Pathol; 2011 Aug; 64(8):683-8. PubMed ID: 21653658
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): a tissue microarray study (TMA).
Evren S; Dermen A; Lockwood G; Fleshner N; Sweet J
Prostate; 2010 Sep; 70(13):1429-36. PubMed ID: 20687216
[TBL] [Abstract][Full Text] [Related]
3. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
[TBL] [Abstract][Full Text] [Related]
4. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
5. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Barbisan F; Mazzucchelli R; Santinelli A; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
Histopathology; 2010 Oct; 57(4):572-9. PubMed ID: 20955382
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
Zhou T; Xu C; He M; Sun Y
Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
[TBL] [Abstract][Full Text] [Related]
7. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Jiang J; Ulbright TM; Zhang S; Eckert GJ; Kao C; Gardner TA; Koch MO; Eble JN; Cheng L
Cancer; 2002 Jul; 95(2):296-300. PubMed ID: 12124829
[TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
9. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
11. Expression of ezrin in prostatic intraepithelial neoplasia.
Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
[TBL] [Abstract][Full Text] [Related]
12. Expression of phosphorylated-mTOR during the development of prostate cancer.
Sutherland SI; Pe Benito R; Henshall SM; Horvath LG; Kench JG
Prostate; 2014 Sep; 74(12):1231-9. PubMed ID: 25043667
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies.
Barbisan F; Mazzucchelli R; Santinelli A; Lopez-Beltran A; Cheng L; Scarpelli M; Montorsi F; Montironi R
Eur Urol; 2009 Jul; 56(1):105-12. PubMed ID: 18468781
[TBL] [Abstract][Full Text] [Related]
14. Loss of 14-3-3sigma in prostate cancer and its precursors.
Cheng L; Pan CX; Zhang JT; Zhang S; Kinch MS; Li L; Baldridge LA; Wade C; Hu Z; Koch MO; Ulbright TM; Eble JN
Clin Cancer Res; 2004 May; 10(9):3064-8. PubMed ID: 15131044
[TBL] [Abstract][Full Text] [Related]
15. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
16. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
[TBL] [Abstract][Full Text] [Related]
18. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.
Uetsuki H; Tsunemori H; Taoka R; Haba R; Ishikawa M; Kakehi Y
J Urol; 2005 Aug; 174(2):514-8. PubMed ID: 16006883
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of phosphorylated mammalian target of rapamycin is associated with poor survival in oesophageal adenocarcinoma: a tissue microarray study.
Prins MJ; Verhage RJ; Ruurda JP; ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2013 Mar; 66(3):224-8. PubMed ID: 23162107
[TBL] [Abstract][Full Text] [Related]
20. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
Delatour NL; Mai KT
Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]